Terms: = Prostate cancer AND PSA AND Prognosis
1671 results:
1. Develop prediction model to help forecast advanced prostate cancer patients' prognosis after surgery using neural network.
Li S; Cai S; Huang J; Li Z; Shi Z; Zhang K; Jiao J; Li W; Pan Y
Front Endocrinol (Lausanne); 2024; 15():1293953. PubMed ID: 38577575
[TBL] [Abstract] [Full Text] [Related]
2. Risk factor analysis and nomogram construction in patients with distant metastatic prostate cancer at different psa levels: a study based on the SEER database.
Li HD; Fan SQ; Qin F; Zhao ST; Kong SP; Ma JG
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2372-2386. PubMed ID: 38567600
[TBL] [Abstract] [Full Text] [Related]
3. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A; Osunkoya AO
Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
[TBL] [Abstract] [Full Text] [Related]
4. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of prostate cancer-Evidence from Serbian Population.
Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507
[TBL] [Abstract] [Full Text] [Related]
6. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
7. A study on the impact of marital status on the survival status of prostate cancer patients based on propensity score matching.
Chen Q; Zhu X; Hu Y; Chen Y; Dai R; Li J; Zhuang J; Lin Y; Zeng Y; You L; Zeng Y; Huang Q
Sci Rep; 2024 Mar; 14(1):6162. PubMed ID: 38485743
[TBL] [Abstract] [Full Text] [Related]
8. Nadir prostate-specific antigen after salvage cryotherapy as a potential prognostic factor for oncologic outcomes.
Carbonell E; Mercader C; Sureda J; Gutiérrez A; Muñoz J; Gallardo E; Feltes N; Mases J; Valduvieco I; Vilaseca A; Franco A; Alcaraz A; Musquera M; Ribal MJ
World J Urol; 2024 Mar; 42(1):133. PubMed ID: 38478102
[TBL] [Abstract] [Full Text] [Related]
9. [Role of Bone Scan Index (BSI) in the prognosis and Treatment Efficacy in Castration-Sensitive prostate cancer Patients with Bone Metastasis].
Deguchi K; Sasaki T; Oue H; Okamoto T; Kato M; Kajiwara S; Higashi S; Masui S; Nishikawa K; Inoue T
Hinyokika Kiyo; 2024 Feb; 70(2):29-37. PubMed ID: 38447942
[TBL] [Abstract] [Full Text] [Related]
10. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
11. Phage Display's Prospects for Early Diagnosis of prostate cancer.
Petrenko VA
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400052
[TBL] [Abstract] [Full Text] [Related]
12. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer.
Sun J; Tian T; Wang N; Jing X; Qiu L; Cui H; Liu Z; Liu J; Yan L; Li D
Front Endocrinol (Lausanne); 2024; 15():1338420. PubMed ID: 38384968
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of the Modeled prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant prostate cancer Treated With Taxanes in FIRSTANA.
Carrot A; Oudard S; Colomban O; Fizazi K; Maillet D; Sartor O; Freyer G; You B
JCO Clin Cancer Inform; 2024 Feb; 8():e2300208. PubMed ID: 38364191
[TBL] [Abstract] [Full Text] [Related]
14. Exposure to heavy metal elements may significantly increase serum prostate-specific antigen levels with overdosed dietary zinc.
Fang Y; Chen C; Chen X; Song J; Feng S; Li Z; Li Z; Xiong Y; Zhang Q; Su H; Liu H; Zhu G; Hu B; Wang W; Liu Z; Jiao K; Zhang C; Zhang F; Jiang K; He J; Sun Z; Yuan D; Chen W; Zhu J
Ecotoxicol Environ Saf; 2024 Mar; 272():116080. PubMed ID: 38350215
[TBL] [Abstract] [Full Text] [Related]
15. Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.
Alaimo A; Genovesi S; Annesi N; De Felice D; Subedi S; Macchia A; La Manna F; Ciani Y; Vannuccini F; Mugoni V; Notarangelo M; Libergoli M; Broso F; Taulli R; Ala U; Savino A; Cortese M; Mirzaaghaei S; Poli V; Bonapace IM; Papotti MG; Molinaro L; Doglioni C; Caffo O; Anesi A; Nagler M; Bertalot G; Carbone FG; Barbareschi M; Basso U; Dassi E; Pizzato M; Romanel A; Demichelis F; Kruithof-de Julio M; Lunardi A
EMBO J; 2024 Mar; 43(5):780-805. PubMed ID: 38316991
[TBL] [Abstract] [Full Text] [Related]
16. prostate cancer: Novel genetic and immunologic biomarkers.
Samare-Najaf M; Kouchaki H; Moein Mahini S; Saberi Rounkian M; Tavakoli Y; Samareh A; Karim Azadbakht M; Jamali N
Clin Chim Acta; 2024 Mar; 555():117824. PubMed ID: 38316287
[TBL] [Abstract] [Full Text] [Related]
17. Copy Number Gain in Androgen Receptors Predicts the Poor prognosis in Japanese Castration-resistant prostate cancer.
Sakamoto S; Ando K; Pae S; Zhao X; Sakai K; Sato K; Saito S; Yamada Y; Rii J; Goto Y; Sazuka T; Imamura Y; Anzai N; Akakura K; Nishio K; Ichikawa T
Anticancer Res; 2024 Feb; 44(2):639-647. PubMed ID: 38307556
[TBL] [Abstract] [Full Text] [Related]
18. Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.
Cui Y; Lin J; Sun D; Zhang H; Diao T; Fu Q
J Cancer Res Clin Oncol; 2024 Jan; 150(2):45. PubMed ID: 38281261
[TBL] [Abstract] [Full Text] [Related]
19. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study.
Murakami Y; Kawahara D; Soyano T; Kozuka T; Takahashi Y; Miyake K; Kashihara K; Kashihara T; Kamima T; Oguchi M; Murakami Y; Yoshioka Y; Nagata Y
Br J Radiol; 2024 Jan; 97(1153):142-149. PubMed ID: 38263831
[TBL] [Abstract] [Full Text] [Related]
20. Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients.
Falkenbach F; Kachanov M; Leyh-Bannurah SR; Maurer T; Knipper S; Köhler D; Graefen M; Sauter G; Budäus L
World J Urol; 2024 Jan; 42(1):38. PubMed ID: 38244095
[TBL] [Abstract] [Full Text] [Related]
[Next]